Lepu Biopharma Co., Ltd. (HKG:2157)

Lepu Biopharma Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	991.34	934.87	367.79	225.35	15.57	-
Revenue Growth	6.04%	154.18%	63.21%	1347.16%	-	-
Gross Profit Gross Profit Growth	882.12	845.28	292.97	197.08	13.57	-
Operating Income Operating Income Growth	-3.27	25.91	-395.84	-390.57	-642.45	-943.68
Net Income Net Income Growth	247.01	261.36	-411.38	-22.1	-689.05	-1,011
Earnings Per Share EPS Growth	0.18	0.15	-0.24	-0.01	-0.42	-0.66
EPS Growth	18.79%	-	-	-	-	-

Revenue by Geography

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
People's Republic of China (PRC) People's Republic of China (PRC) Growth	571.08	571.08	345.83	101.39	15.57
Overseas Overseas Growth	363.79	363.79	21.96	123.97	-
Total Total Growth	934.87	934.87	367.79	225.35	15.57

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	788.99	959.78	475.99	498.43	678.2	214.24
Total Debt Total Debt Growth	1,180	1,064	850.16	746.82	690.3	335.26
Net Cash (Debt) Net Cash Growth	-391.5	-104.05	-374.17	-248.4	-12.1	-121.03
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-0.28	-0.06	-0.22	-0.15	-0.01	-0.08

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	-	-12.23	-196.39	-250.84	-480.93	-621.74
Capital Expenditures CapEx Growth	-	-45.41	-32.92	-28	-110.45	-213.39
Free Cash Flow Free Cash Flow Growth	-	-57.64	-229.31	-278.84	-591.38	-835.12
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	88.98%	90.42%	79.66%	87.45%	87.12%	-
Operating Margin	-0.33%	2.77%	-107.62%	-173.32%	-4125.67%	-
Pretax Margin	25.83%	27.88%	-115.33%	-13.45%	-4491.66%	-
Profit Margin	24.92%	27.96%	-111.85%	-9.80%	-4424.94%	-
FCF Margin	-	-6.17%	-62.35%	-123.73%	-3797.71%	-

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	20.74	30.83	-	-	-	-
PS Ratio	6.68	8.62	11.45	28.14	692.84	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 20, 2026

Data Sources Report a data error